Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CLLS compared with SGHT: revenue, margins and what each company keeps, and the suppliers and customers both name
CLLS
Cellectis S.A.
Change
Mkt cap
Revenue
Revenue
SGHT
Sight Sciences, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
CLLS
Cellectis S.A.
vs
SGHT
Sight Sciences, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
CLLS
Cellectis S.A.
Change
1.11
▼
−5.13%
Mkt cap
$108.4M
Revenue
—
Revenue
—
SGHT
Sight Sciences, Inc.
Change
9.48
▲
+1.73%
Regular session
Nov 2 '26
Mkt cap
$513.4M
Revenue
$23M
Q2 FY26
Revenue
$77M
FY25
vs
Compare
Regular session
Nov 2 '26
CLLS
Cellectis S.A.
vs
SGHT
Sight Sciences, Inc.
1.11
▼
−5.13%
Price
9.48
▲
+1.73%
$108.4M
Mkt cap
$513.4M
—
Revenue
$23M
Q2 FY26
—
Revenue
$77M
FY25
Change
Change
CLLS
1.11
▼
−5.13%
vs
SGHT
9.48
▲
+1.73%
Regular session
Nov 2 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
CLLS: latest quarter not drawable. SGHT: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only CLLS
4
TMO
Life Technologies
supplier
ALLO
Allogene Therapeutics
customer
AZN
AstraZeneca AB (AZ Ireland)
customer
—
Servier
unlisted
customer
Shared
0
No disclosed counterparties: SGHT.
Only SGHT
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
CLLS, solid
SGHT, dashed